A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity.

Moreau, P

A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity. [electronic resource] - British journal of haematology Dec 1996 - 527-30 p. digital

Publication Type: Journal Article

0007-1048

10.1046/j.1365-2141.1996.d01-1932.x doi


Adolescent
Adult
Combined Modality Therapy
Female
Hematopoietic Stem Cell Transplantation--methods
Hodgkin Disease--drug therapy
Humans
Leukemia, Myeloid, Acute--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Male
Melphalan--adverse effects
Multiple Myeloma--drug therapy
Pilot Projects
Transplantation, Autologous